Renaissance Capital logo

CoLabs Int’l Withdrawn, Nasdaq: CLLB

Makes skin care products designed to limit unwanted chemical absorption.

Industry: Consumer Staples

Latest Trade: ()

First Day Return:

Return from IPO:

Industry: Consumer Staples

Our technology places OTC drugs, pharmaceuticals, chemicals, and agrochemicals into micro-sized, electrostatically charged encapsulates as well as into other types of micro-encapsulates. These encapsulates are then suspended in uniquely designed formulations. This formulation of a highly advanced micro-technology can: target the delivery of topically applied drugs; limit unwanted absorption of chemicals, drugs, and cosmetics through the skin; and provide a designed release of active ingredients with a prescribed depth of skin penetration. We have already developed commercially unique and innovative targeted skin delivery systems for topical pharmacology. Our technology limits unwanted side effects that can occur as a result of absorption through the skin. The penetration of chemicals through the skin can have serious impact on the body’s organs and systems. Our current applications include anti-bacterial/viral sanitizers/soaps, sunscreens, pest-repellents, and healing cosmetic lotions. For consumers, we provide elegant skin delivery of topically applied drugs and cosmetics. This combined end purpose is the unique foundation of our technology.
more less
IPO Data
IPO File Date 03/27/2023
Offer Price
Price Range $4.00 - $5.00
Offer Shares (mm) 1.3
Deal Size ($mm) $6
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date
Offer Price
Price Range $4.00 - $5.00
Offer Shares (mm) 1.3
Deal Size ($mm) $6
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
Craft Capital Management
R.F. Lafferty & Co.
Company Data
Headquarters Huntington Beach, CA, United States
Founded 2008
Employees 11
Website www.colabsintl.com

CoLabs Int’l (CLLB) Performance